See also Assisted Reproductive Technology
- Caution over revolutionary infertility treatment - WHW Sept 2001
- Pesticides decrease fertility - WHW Sept 1999
- Protecting Our Future The Case for Greater Regulation of Assisted Reproductive Technology. 1999
- Infertility drugs and ovarian cancer - WHW Dec 1998
September 2001 Women's Health Watch
The use of the revolutionary new infertility treatment intracytoplasmic sperm injection (ICSI) should be limited to male-factor infertility, according to a review in The Lancet.
Professor Sergio Oehninger from Eastern Virginia Medical School writes that male factors are the commonest cause of infertility and ICSI has revolutionized the approach to treating infertility caused by sperm dysfunction. Professor Oehninger says ICSI is commonly used when the cause of sperm abnormalities cannot be determined but he warns that the technique bypasses natural sperm-selection barriers. This means there could be an increased risk of passing on chromosomal or genetic disease, resulting in malformation or cancer.... Read More
September 1999 Women's Health Watch
Exposure to pesticides affects male fertility, according to a Dutch study. Researchers investigated 836 couples seeking in-vitro fertilisation to determine how exposure to pesticides affected the man's ability to conceive. They found fertilisation rates dropped significantly when male partners are occupationally exposed to pesticides.
Ref: Lancet, 1999; 354: 9177
A thought-provoking examination of the current issues in ART in New Zealand.
Edited by Sandra Coney and Anne Else,
Published by Women's Health Action Availible here
December 1998 Women's Health Watch
A new study has failed to confirm an association between ovarian cancer and drugs used to stimulate ovulation during infertility treatment.
Researchers at Australia's Monash University studied more than l0,000 women who underwent in vitro fertilisation treatment 1978, and 1992. Just over half the women studied used at least one cycle of ovarian-stimulating drugs and the other group did not. Researcher say there was no difference in the incidence of ovarian cancer in the two groups with three cases of invasive ovarian cancer occurring in each group. The Monash researchers are now conducting a similar study involving about 30,000 women.... Read More
Next page: Assisted Reproductive Technology